Polymorphisms in DNA damage response genes and head and neck cancer risk

Biomarkers

Volumn 15, Issue 5, 2010, Pages 379-399

  Flores Obando, Rafael E ^a   Gollin, Susanne M ^b   Ragin, Camille C ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

DNA repair genes; ERCC1; XP; XRCC1; XRCC3

Indexed keywords

ALCOHOL; XRCC1 PROTEIN;

5' UNTRANSLATED REGION; CANCER RISK; CASE CONTROL STUDY; CAUCASIAN; CODON; DNA DAMAGE; DNA POLYMORPHISM; DNA REPAIR; ETHNICITY; GENETIC VARIABILITY; HEAD AND NECK CANCER; HUMAN; NONHUMAN; REVIEW; SMOKING; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; WART VIRUS;

CASE-CONTROL STUDIES; CODON; DNA-BINDING PROTEINS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HEAD AND NECK NEOPLASMS; HUMANS; POLYMORPHISM, GENETIC;

HUMAN PAPILLOMAVIRUS;

EID: 77954840629     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/13547501003797664     Document Type: Review

References (79)

1. Abbasi R, Ramroth H, Becher H, Dietz A, Schmezer P, Popanda O. (2009). Laryngeal cancer risk associated with smoking and alcohol consumption is modified by genetic polymorphisms in ERCC5, ERCC6 and RAD23B but not by polymorphisms in five other nucleotide excision repair genes. Int J Cancer 125:1431-1439
2. Altieri F, Grillo C, Maceroni M, Chichiarelli S. (2008). DNA damage and repair: from molecular mechanisms to health implications. Antioxid Redox Signal 10:891-937.
3. An J, Liu Z, Hu Z, Li G, Wang LE, Sturgis EM, El-Naggar AK, Spitz MR, Wei Q. (2007). Potentially functional single nucleotide polymorphisms in the core nucleotide excision repair genes and risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev 16:1633-1638 (Pubitemid 47294830)
4. Applebaum KM, Nelson HH, Zens MS, Stukel TA, Spencer SK, Karagas MR. (2009). Oral contraceptives: a risk factor for squamous cell carcinoma? J Invest Dermatol 129:2760-2765
5. Arbes SJ Jr, Olshan AF, Caplan DJ, Schoenbach VJ, Slade GD, Symons MJ. (1999). Factors contributing to the poorer survival of black Americans diagnosed with oral cancer (United States). Cancer Causes Control 10:513-523
6. Bau DT, Tsai MH, Huang CY, Lee CC, Tseng HC, Lo YL, Tsai Y, Tsai FJ. (2007). Relationship between polymorphisms of nucleotide excision repair genes and oral cancer risk in Taiwan: evidence for modification of smoking habit. Chin J Physiol 50:294-300.
7. Benhamou S, Tuimala J, Bouchardy C, Dayer P, Sarasin A, Hirvonen A. (2004). DNA repair gene XRCC2 and XRCC3 polymorphisms and susceptibility to cancers of the upper aerodigestive tract. Int J Cancer 112:901-904
8. Bozec A, Formento P, Lassalle S, Lippens C, Hofman P, Milano G. (2007). Dual inhibition of EGFR and VEGFR pathways in combination with irradiation: antitumour supra-additive effects on human head and neck cancer xenografts. Br J Cancer 97:65-72.
9. Buch S, Zhu B, Davis AG, Odom D, Siegfried JM, Grandis JR, Romkes M. (2005). Association of polymorphisms in the cyclin D1 and XPD genes and susceptibility to cancers of the upper aero-digestive tract. Mol Carcinog 42:222-228
10. Carles J, Monzo M, Amat M, Jansa S, Artells R, Navarro A, Foro P, Alameda F, Gayete A, Gel B, Miguel M, Albanell J, Fabregat X. (2006). Single-nucleotide polymorphisms in base excision repair, nucleotide excision repair, and double strand break genes as markers for response to radiotherapy in patients with stage I to II head-and-neck cancer. Int J Radiat Oncol Biol Phys 66: 1022-1030
11. Cheng L, Sturgis EM, Eicher SA, Spitz MR, Wei Q. (2002). Expression of nucleotide excision repair genes and the risk for squamous cell carcinoma of the head and neck. Cancer 94:393-397 (Pubitemid 34081368)
12. Csejtei A, Tibold A, Koltai K, Varga Z, Szanyi I, Gobel G, Prantner I, Steffler D, Feher G, De Blasio A, Ember I, Kiss I. (2009). Association between XRCC1 polymorphisms and head and neck cancer in a Hungarian population. Anticancer Res 29:4169-4173
13. Demokan S, Demir D, Suoglu Y, Kiyak E, Akar U, Dalay N. (2005). Polymorphisms of the XRCC1 DNA repair gene in head and neck cancer. Pathol Oncol Res 11:22-25
14. Fountzilas G, Bamias A, Kalogera-Fountzila A, Karayannopoulou G, Bobos M, Athanassiou E, Kalogeras KT, Tolis C, Tsekeris P, Papakostas P, Vamvouka C, Zaramboukas T, Kosmidis P, Zamboglou N, Misailidou D. (2009). Induction chemotherapy with docetaxel and cisplatin followed by concomitant chemoradiotherapy in patients with inoperable non-nasopharyngeal carcinoma of the head and neck. Anticancer Res 29:529-538
15. Gajecka M, Rydzanicz M, Jaskula-Sztul R, Kujawski M, Szyfter W, Szyfter K. (2005a). CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma. Mutat Res 574:112-123
16. Gajecka M, Rydzanicz M, Jaskula-Sztul R, Wierzbicka M, Szyfter W, Szyfter K. (2005b). Reduced DNA repair capacity in laryngeal cancer subjects. A comparison of phenotypic and genotypic results. Adv Otorhinolaryngol 62:25-37.
17. Gal TJ, Huang WY, Chen C, Hayes RB, Schwartz SM. (2005). DNA repair gene polymorphisms and risk of second primary neoplasms and mortality in oral cancer patients. Laryngoscope 115:2221-2231
18. Geisler SA, Olshan AF, Cai J, Weissler M, Smith J, Bell D. (2005). Glutathione S-transferase polymorphisms and survival from head and neck cancer. Head Neck 27:232-242
19. Goodwin WJ, Thomas GR, Parker DF, Joseph D, Levis S, Franzmann E, Anello C, Hu JJ. (2008). Unequal burden of head and neck cancer in the United States. Head Neck 30:358-371
20. Gourin CG, Podolsky RH. (2006). Racial disparities in patients with head and neck squamous cell carcinoma. Laryngoscope 116:1093-1106
21. Grau JJ, Caballero M, Campayo M, Jansa S, Vargas M, Alos L, Monzo M. (2009). Gene single nucleotide polymorphism accumulation improves survival in advanced head and neck cancer patients treated with weekly paclitaxel. Laryngoscope 119:1484-1490
22. Hakem R. (2008). DNA-damage repair; the good, the bad, and the ugly. EMBO J 27:589-605.
23. Hall J, Hashibe M, Boffetta P, Gaborieau V, Moullan N, Chabrier A, Zaridze D, Shangina O, Szeszenia-Dabrowska N, Mates D, Janout V, Fabianova E, Holcatova I, Hung RJ, McKay J, Canzian F, Brennan P. (2007). The association of sequence variants in DNA repair and cell cycle genes with cancers of the upper aerodigestive tract. Carcinogenesis 28:665-671
24. Handra-Luca A, Hernandez J, Mountzios G, Taranchon E, Lacau-St-Guily J, Soria JC, Fouret P. (2007). Excision repair cross complementation group 1 immunohistochemical expression predicts objective response and cancer-specific survival in patients treated by cisplatin-based induction chemotherapy for locally advanced head and neck squamous cell carcinoma. Clin Cancer Res 13:3855-3859
25. Harbord RM, Egger M, Sterne JA. (2006). A modified test for smallstudy effects in meta-analyses of controlled trials with binary endpoints. Stat Med 25:3443-3457
26. Harth V, Schafer M, Abel J, Maintz L, Neuhaus T, Besuden M, Primke R, Wilkesmann A, Thier R, Vetter H, Ko YD, Bruning T, Bolt HM, Ickstadt K. (2008). Head and neck squamous-cell cancer and its association with polymorphic enzymes of xenobiotic metabolism and repair. J Toxicol Environ Health A 71:887-897
27. Higgins JP, Thompson SG, Deeks JJ, Altman DG. (2003). Measuring inconsistency in meta-analyses. BMJ 327:557-560
28. Hoeijmakers JH. (2001). Genome maintenance mechanisms for preventing cancer. Nature 411:366-374
29. Hou SM, Falt S, Angelini S, Yang K, Nyberg F, Lambert B, Hemminki K. (2002). The XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk. Carcinogenesis 23:599-603.
30. Hsieh LL, Chien HT, Chen IH, Liao CT, Wang HM, Jung SM, Wang PF, Chang JT, Chen MC, Cheng AJ. (2003). The XRCC1 399Gln polymorphism and the frequency of p53 mutations in Taiwanese oral squamous cell carcinomas. Cancer Epidemiol Biomarkers Prev 12:439-443
31. Huang WY, Olshan AF, Schwartz SM, Berndt SI, Chen C, Llaca V, Chanock SJ, Fraumeni JF, Jr., Hayes RB. (2005). Selected genetic polymorphisms in MGMT, XRCC1, XPD, and XRCC3 and risk of head and neck cancer: a pooled analysis. Cancer Epidemiol Biomarkers Prev 14:1747-1753
32. Ioannidis JP, Patsopoulos NA, Evangelou E. (2007). Uncertainty in heterogeneity estimates in meta-analyses. BMJ 335:914-916
33. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. (2009). Cancer statistics, 2009. CA Cancer J Clin 59:225-249
34. Jun HJ, Ahn MJ, Kim HS, Yi SY, Han J, Lee SK, Ahn YC, Jeong HS, Son YI, Baek JH, Park K. (2008). ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation. Br J Cancer 99:167-172
35. Kietthubthew S, Sriplung H, Au WW, Ishida T. (2006). Polymorphism in DNA repair genes and oral squamous cell carcinoma in Thailand. Int J Hyg Environ Health 209:21-29
36. Koh Y, Kim TM, Jeon YK, Kwon TK, Hah JH, Lee SH, Kim DW, Wu HG, Rhee CS, Sung MW, Kim CW, Kim KH, Heo DS. (2009). Class III beta-tubulin, but not ERCC1, is a strong predictive and prognostic marker in locally advanced head and neck squamous cell carcinoma. Ann Oncol 20:1414-1419
37. Kornguth DG, Garden AS, Zheng Y, Dahlstrom KR, Wei Q, Sturgis EM. (2005). Gastrostomy in oropharyngeal cancer patients with ERCC4 (XPF) germline variants. Int J Radiat Oncol Biol Phys 62: 665-671
38. Kowalski M, Przybylowska K, Rusin P, Olszewski J, Morawiec-Sztandera A, Bielecka-Kowalska A, Pietruszewska W, Mlynarski W, Janusz S, Majsterek I. (2009). Genetic polymorphisms in DNA base excision repair gene XRCC1 and the risk of squamous cell carcinoma of the head and neck. J Exp Clin Cancer Res 28:37.
39. Li C, Wang LE, Wei Q. (2009). DNA repair phenotype and cancer susceptibility - a mini review. Int J Cancer 124:999-1007.
40. Majumder M, Indra D, Roy PD, Datta S, Ray JG, Panda CK, Roy B. (2009). Variant haplotypes at XRCC1 and risk of oral leukoplakia in HPV non-infected samples. J Oral Pathol Med 38:174-180
41. Majumder M, Sikdar N, Ghosh S, Roy B. (2007). Polymorphisms at XPD and XRCC1 DNA repair loci and increased risk of oral leukoplakia and cancer among NAT2 slow acetylators. Int J Cancer 120:2148-2156
42. Majumder M, Sikdar N, Paul RR, Roy B. (2005). Increased risk of oral leukoplakia and cancer among mixed tobacco users carrying XRCC1 variant haplotypes and cancer among smokers carrying two risk genotypes: one on each of two loci, GSTM3 and XRCC1 (codon 280). Cancer Epidemiol Biomarkers Prev 14:2106-2112
43. Manuguerra M, Saletta F, Karagas MR, Berwick M, Veglia F, Vineis P, Matullo G. (2006). XRCC3 and XPD/ERCC2 single nucleotide polymorphisms and the risk of cancer: a HuGE review. Am J Epidemiol 164:297-302.
44. Matullo G, Dunning AM, Guarrera S, Baynes C, Polidoro S, Garte S, Autrup H, Malaveille C, Peluso M, Airoldi L, Veglia F, Gormally E, Hoek G, Krzyzanowski M, Overvad K, Raaschou-Nielsen O, Clavel-Chapelon F, Linseisen J, Boeing H, Trichopoulou A, Palli D, Krogh V, Tumino R, Panico S, Bueno-De-Mesquita HB, Peeters PH, Lund E, Pera G, Martinez C, Dorronsoro M, Barricarte A, Tormo MJ, Quiros JR, Day NE, Key TJ, Saracci R, Kaaks R, Riboli E, Vineis P. (2006). DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis 27: 997-1007.
45. Michiels S, Danoy P, Dessen P, Bera A, Boulet T, Bouchardy C, Lathrop M, Sarasin A, Benhamou S. (2007). Polymorphism discovery in 62 DNA repair genes and haplotype associations with risks for lung and head and neck cancers. Carcinogenesis 28:1731-1739
46. Olshan AF, Watson MA, Weissler MC, Bell DA. (2002). XRCC1 polymorphisms and head and neck cancer. Cancer Lett 178:181-186
47. Parkin DM, Bray F, Ferlay J, Pisani P. (2005). Global cancer statistics, 2002. CA Cancer J Clin 55:74-108.
48. Quintela-Fandino M, Hitt R, Medina PP, Gamarra S, Manso L, Cortes-Funes H, Sanchez-Cespedes M. (2006). DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy. J Clin Oncol 24:4333-4339
49. Ragin CC, Langevin S, Rubin S, Taioli E. (2010). Review of studies on metabolic genes and cancer in populations of African descent. Genet Med 12:12-18.
50. Ragin CC, Reshmi SC, Gollin SM. (2004). Mapping and analysis of HPV16 integration sites in a head and neck cancer cell line. Int J Cancer 110:701-709
51. Ragin CC, Taioli E. (2007). Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer 121:1813-1820
52. Ragin CC, Taioli E, Weissfeld JL, White JS, Rossie KM, Modugno F, Gollin SM. (2006). 11q13 amplification status and human papillomavirus in relation to p16 expression defines two distinct etiologies of head and neck tumours. Br J Cancer 95:1432-1438
53. Ramachandran S, Ramadas K, Hariharan R, Rejnish Kumar R, Radhakrishna Pillai M. (2006). Single nucleotide polymorphisms of DNA repair genes XRCC1 and XPD and its molecular mapping in Indian oral cancer. Oral Oncol 42: 350-362
54. Reshmi SC, Gollin SM. (2005). Chromosomal instability in oral cancer cells. J Dent Res 84:107-117
55. Rusin P, Markiewicz L, Majsterek I. (2008). [Genetic predeterminations of head and neck cancer]. Postepy Hig Med Dosw (Online) 62:490-501.
56. Rydzanicz M, Wierzbicka M, Gajecka M, Szyfter W, Szyfter K. (2005). The impact of genetic factors on the incidence of multiple primary tumors (MPT) of the head and neck. Cancer Lett 224:263-278
57. Scully C, Bagan J. (2009). Oral squamous cell carcinoma: overview of current understanding of aetiopathogenesis and clinical implications. Oral Dis 15:388-399
58. Seker H, Butkiewicz D, Bowman ED, Rusin M, Hedayati M, Grossman L, Harris CC. (2001). Functional significance of XPD polymorphic variants: attenuated apoptosis in human lymphoblastoid cells with the XPD 312 Asp/Asp genotype. Cancer Res 61: 7430-7434
59. Shen H, Sturgis EM, Khan SG, Qiao Y, Shahlavi T, Eicher SA, Xu Y, Wang X, Strom SS, Spitz MR, Kraemer KH, Wei Q. (2001). An intronic poly (AT) polymorphism of the DNA repair gene XPC and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Res 61:3321-3325
60. Shen MR, Jones IM, Mohrenweiser H. (1998). Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res 58:604-608
61. Sturgis EM, Castillo EJ, Li L, Eicher SA, Strom SS, Spitz MR, Wei Q. (2002a). XPD/ERCC2 exon8 polymorphisms: rarity and lack of significance in risk of squamous cell carcinoma of the head and neck. Oral Oncol 38:475-477 (Pubitemid 34756733)
62. Sturgis EM, Castillo EJ, Li L, Zheng R, Eicher SA, Clayman GL, Strom SS, Spitz MR, Wei Q. (1999). Polymorphisms of DNA repair gene XRCC1 in squamous cell carcinoma of the head and neck. Carcinogenesis 20:2125-2129
63. Sturgis EM, Dahlstrom KR, Spitz MR, Wei Q. (2002b). DNA repair gene ERCC1 and ERCC2/XPD polymorphisms and risk of squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 128:1084-1088 (Pubitemid 35014604)
64. Sturgis EM, Zheng R, Li L, Castillo EJ, Eicher SA, Chen M, Strom SS, Spitz MR, Wei Q. (2000). XPD/ERCC2 polymorphisms and risk of head and neck cancer: a case-control analysis. Carcinogenesis 21:2219-2223
65. Sugimura T, Kumimoto H, Tohnai I, Fukui T, Matsuo K, Tsurusako S, Mitsudo K, Ueda M, Tajima K, Ishizaki K. (2006). Gene- environment interaction involved in oral carcinogenesis: molecular epidemiological study for metabolic and DNA repair gene polymorphisms. J Oral Pathol Med 35:11-18.
66. Tae K, Lee HS, Park BJ, Park CW, Kim KR, Cho HY, Kim LH, Park BL, Shin HD. (2004). Association of DNA repair gene XRCC1 polymorphisms with head and neck cancer in Korean population. Int J Cancer 111:805-808
67. Varzim G, Monteiro E, Silva RA, Fernandes J, Lopes C. (2003). CYP1A1 and XRCC1 gene polymorphisms in SCC of the larynx. Eur J Cancer Prev 12:495-499
68. Vineis P, Manuguerra M, Kavvoura FK, Guarrera S, Allione A, Rosa F, Di Gregorio A, Polidoro S, Saletta F, Ioannidis JP, Matullo G. (2009). A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility. J Natl Cancer Inst 101:24-36.
69. Wang Y, Spitz MR, Lee JJ, Huang M, Lippman SM, Wu X. (2007). Nucleotide excision repair pathway genes and oral premalignant lesions. Clin Cancer Res 13:3753-3758
70. Wei Q, Wang LE, Sturgis EM, Mao L. (2005). Expression of nucleotide excision repair proteins in lymphocytes as a marker of susceptibility to squamous cell carcinomas of the head and neck. Cancer Epidemiol Biomarkers Prev 14:1961-1966
71. Wen SX, Zhang XM, Tang PZ, Zhao D, Guo YL, Tan W, Lin DX. (2007). [Association between genetic polymorphism in DNA repair genes XRCC3 and risks of laryngeal and hypopharyngeal carcinomas]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 42:856-859
72. Werbrouck J, De Ruyck K, Duprez F, Van Eijkeren M, Rietzschel E, Bekaert S, Vral A, De Neve W, Thierens H. (2008). Singlenucleotide polymorphisms in DNA double-strand break repair genes: association with head and neck cancer and interaction with tobacco use and alcohol consumption. Mutat Res 656:74-81.
73. Werbrouck J, De Ruyck K, Duprez F, Veldeman L, Claes K, Van Eijkeren M, Boterberg T, Willems P, Vral A, De Neve W, Thierens H. (2009). Acute normal tissue reactions in head-andneck cancer patients treated with IMRT: influence of dose and association with genetic polymorphisms in DNA DSB repair genes. Int J Radiat Oncol Biol Phys 73:1187-1195
74. Whitehead A, Whitehead J. (1991). A general parametric approach to the meta-analysis of randomized clinical trials. Stat Med 10:1665-1677
75. Yang H, Lippman SM, Huang M, Jack Lee J, Wang W, Spitz MR, Wu X. (2008a). Genetic polymorphisms in double-strand break DNA repair genes associated with risk of oral premalignant lesions. Eur J Cancer 44:1603-1611
76. Yang M, Kang MJ, Choi Y, Kim CS, Lee SM, Park CW, Lee HS, Tae K. (2005). Associations between XPC expression, genotype, and the risk of head and neck cancer. Environ Mol Mutagen 45: 374-379
77. Yang M, Kim WH, Choi Y, Lee SH, Kim KR, Lee HS, Tae K. (2006). Effects of ERCC1 expression in peripheral blood on the risk of head and neck cancer. Eur J Cancer Prev 15:269-273
78. Yang Y, Tian H, Zhang ZJ. (2008b). [Association of the XRCC1 and hOGG1 polymorphisms with the risk of laryngeal carcinoma]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 25:211-213
79. Yen CY, Liu SY, Chen CH, Tseng HF, Chuang LY, Yang CH, Lin YC, Wen CH, Chiang WF, Ho CH, Chen HC, Wang ST, Lin CW, Chang HW. (2008). Combinational polymorphisms of four DNA repair genes XRCC1, XRCC2, XRCC3, and XRCC4 and their association with oral cancer in Taiwan. J Oral Pathol Med 37:271-277